Could 'controversial' Pharma Court Ruling Provide 'Wiggle Room' for Off-Label

Could 'controversial' pharma court ruling provide 'wiggle room' for off-label

Filed under: drug treatment programs in nyc

Offering a word of caution, Marc Ullman from New York firm, Ullman, Shapiro & Ullman LLP, told us that the Second Circuit Court decision in the off-label use case is very interesting – “though I think more for what is says about the trend in favor of …
Read more on NutraIngredients-usa.com

 

Gene target shows promise for autism

Filed under: drug treatment programs in nyc

… breast cancer. The findings, which appear in the latest issue of Nature, provide a pathway to the creation of pharmaceuticals aimed at treating autism spectrum disorders (ASD) that are associated with diminished social interaction skills, impaired …
Read more on Futurity: Research News